Most men start fertility treatment focused on one outcome: a pregnancy. The long-term health effects of the treatment itself rarely get the same attention. That gap matters, because several of the most common approaches alter hormonal signaling and those changes can persist after the prescription ends.
This guide covers hormonal medications, surgery, and sperm retrieval. It does not cover testosterone replacement therapy, which is a separate topic and usually counterproductive for sperm production.
What counts as a male fertility treatment
Common male fertility treatments fall into three groups. Hormonal medication, usually taken for three to six months. Surgery, most often for varicocele or obstruction. Sperm retrieval paired with assisted reproduction such as IVF or ICSI. Lifestyle changes like sleep, weight management, and cutting alcohol are standard first steps, but most men and their doctors do not call those treatments in the same way.
Hormonal medications
Several medications used in male fertility work by changing the signals between the brain and the testicles. They are generally used off-label, meaning regulatory agencies have not approved them specifically for male infertility. That matters for long-term data, because off-label use often comes with shorter and thinner follow-up studies.
Clomiphene citrate
Clomiphene is a selective estrogen receptor modulator. In men, it blocks estrogen receptors in the hypothalamus and pituitary gland. The brain responds by releasing more luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Those hormones tell the testicles to produce more testosterone and sperm. Many men see a rise in total testosterone and improved sperm counts within three months, though individual responses vary.
The long-term data are limited. Most published series follow men for 6 to 12 months. Within that window, the side effects that matter most are visual changes. Blurred vision, light sensitivity, and seeing halos around lights are rare but serious. When they appear, the medication is usually stopped. In most reported cases the symptoms resolve, but a small number of men describe lasting visual changes. Because of that, many reproductive urologists recommend an eye exam before starting clomiphene and again if any visual symptom appears.
Mood changes are more common than visual ones. Some men feel more irritable, anxious, or low while taking clomiphene. These effects tend to fade after stopping, but a few men report that the low mood lasts weeks or months. Sorting out whether that comes from the drug, the underlying hormone imbalance, or the stress of fertility treatment is difficult.
Because clomiphene can raise testosterone, some of that testosterone converts to estradiol. This can cause breast tenderness, mild gynecomastia, or acne. Those effects are usually reversible once treatment stops. There is no convincing evidence that short-term clomiphene use in men carries long-term cardiovascular or bone risk. No large, decades-long trial has been done.
Letrozole and other aromatase inhibitors
Aromatase inhibitors such as letrozole are sometimes used in place of clomiphene. They lower estradiol, which prompts the pituitary to increase testosterone and, in some men, improve sperm parameters.
The long-term concern with this class of medication is bone density. Chronically low estrogen can contribute to bone loss in men, just as it can in women. In men taking aromatase inhibitors for months, some studies note a small decline in bone mineral density markers. Joint pain and changes in cholesterol are also reported. The follow-up data are short. For men who remain on these medications for extended periods, bone density monitoring is usually part of the picture, but that decision sits with the prescribing specialist.
hCG and FSH injections
Human chorionic gonadotropin (hCG) acts like LH. It directly stimulates the Leydig cells in the testicles to produce testosterone. FSH injections, often used in combination, act on Sertoli cells to support sperm production. These injections are common for men whose pituitary is not signaling the testicles properly.
While on hCG, rising testosterone and estradiol levels can feed back to suppress the brain's own LH and FSH release. This is why these medications are often given in cycles or with careful monitoring. After stopping, the axis generally recovers, but recovery can take weeks to months. Some men describe a temporary dip in energy and mood during that recovery period, which makes sense if natural testosterone has not fully bounced back.
Potential longer-term side effects include gynecomastia, acne, and testicular discomfort. Those are driven by elevated estradiol or sustained stimulation. They are usually reversible, though gynecomastia that develops late can persist if breast tissue has formed. The concern that prolonged continuous high-dose hCG could make the testicles less responsive is based on animal data and case reports, not large human trials.
FSH injections carry fewer hormonal feedback problems because they do not directly raise testosterone. The main long-term considerations are cost, inconvenience, and the rare possibility of developing antibodies to the medication.
Surgery
Varicocele repair
Varicocele repair is one of the most studied surgeries in male fertility. The long-term health effects are mostly surgical rather than hormonal. The risks include hydrocele, which is a fluid collection around the testicle, recurrence of the varicocele, and infection. Hydrocele formation is the most common longer-term issue, occurring in a small percentage of men. Testicular atrophy from damage to the testicular artery is a serious but uncommon complication.
From a general health standpoint, varicocelectomy does not appear to cause long-term hormonal harm. Some studies show a modest improvement in testosterone in men who had low levels before surgery, but the effect is not universal. Most men recover within a week or two and do not think about the surgery again.
Surgical sperm retrieval
For men with no sperm in the ejaculate, procedures such as TESE or microTESE retrieve sperm directly from the testicle or epididymis. The long-term effects on the man are local. Scarring, chronic pain, and reduced testicular size are possible, especially after repeated procedures. MicroTESE removes small samples of testicular tissue, so a single procedure rarely alters hormone production enough to matter. Multiple procedures could, in theory, reduce the amount of tissue available for sperm and testosterone production, but long-term outcome data are sparse.
Epididymal procedures like PESA are less invasive and usually do not affect long-term testicular function.
Assisted reproduction and mental health
The man's physical health is not the only long-term effect. Fertility treatment, including multiple cycles of IVF or ICSI, can stretch relationships and finances over years. Research on men's mental health during fertility treatment finds elevated rates of anxiety and depression compared to the general population. These effects can outlast the treatment itself. Men often delay seeking support because the focus stays on the partner's body or the outcome. The long-term health effect of that emotional strain is real and worth naming.
What the evidence does not answer
Several honest gaps exist. There are no large randomized trials following men for ten years after clomiphene, hCG, or letrozole. Most data come from retrospective series with follow-up of 6 to 12 months. That means the long-term risks of cardiovascular events, bone fractures, or persistent mood changes are not well quantified. The treatments are widely used, and serious long-term harms appear uncommon, but absence of evidence is not the same as evidence of absence.
Practical monitoring
Because long-term data are thin, the practical approach is monitoring rather than avoidance. For men on clomiphene, that means reporting any visual change immediately and getting an eye exam if one occurs. For men on hCG or letrozole, it means periodic blood tests for testosterone, estradiol, and liver or lipid markers as recommended by the prescribing clinician. For men after surgery, it means attending follow-up ultrasounds and reporting persistent pain or swelling. None of this is medical advice. It is a description of what responsible monitoring tends to look like.
Most men tolerate common fertility treatments without permanent health changes. The hormonal medications are generally reversible in their effects on sperm and testosterone once stopped. The surgical procedures carry mostly local, low-frequency risks that show up within the first year. The biggest long-term unknowns are cardiovascular and bone outcomes for the off-label hormonal drugs, because the follow-up has not been done. That does not make the treatments unsafe. It makes thoughtful monitoring part of the deal.
This content is for educational purposes only and is not medical advice. Oakman products are designed for physical comfort and cooling. They make no claims about fertility, sperm quality, or hormone levels. Consult a healthcare professional for personalized advice.